General Statement of Disclosure:

CONSULTING FEES/HONORARIA: GlaxoSmithKline(MODEST), Eli-Lilly(MODEST), Haemoscope (MODEST), sanofi-aventis(MODEST), Daiichi-Sankyo(MODEST), Astra Zeneca(SIGNIFICANT), Boehringer-Ingelheim(SIGNIFICANT), Bristol-Myers Squibb(SIGNIFICANT), Pfizer Inc(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Servier(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Boehringer-Ingelheim(SIGNIFICANT), GlaxoSmithKline(SIGNIFICANT), Bristol-Myers Squibb(SIGNIFICANT), sanofi-aventis(SIGNIFICANT), Pfizer(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT)

View Full Disclosure